These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20380807)

  • 21. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
    Qiu W; Zhou G; Zhai Y; Zhang X; Xie W; Zhang H; Yang H; Zhi L; Yuan X; Zhang X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2514-8. PubMed ID: 18768525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma].
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and analysis of cSNP chip on hepatocellular carcinoma-related genes.
    Wang J; Ni H; Chen L; Liu YX; Chen CB; Song WQ
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):398-402. PubMed ID: 16109524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of CYP450 and cancer susceptibility.
    Han XM; Zhou HH
    Acta Pharmacol Sin; 2000 Aug; 21(8):673-9. PubMed ID: 11501173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warning: Genome-wide association studies can be misleading. An example in hepatology.
    Galichon P; Hertig A; Rondeau E; Mesnard L
    Hepatology; 2011 Apr; 53(4):1408; author reply 1408-9. PubMed ID: 21480354
    [No Abstract]   [Full Text] [Related]  

  • 28. No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantation.
    Li XD; Wu LM; Xie HY; Xu X; Zhou L; Liang TB; Wang WL; Shen Y; Zhang M; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):254-8. PubMed ID: 17548247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNFR1 promoter -329G/T polymorphism results in allele-specific repression of TNFR1 expression.
    Kim S; Moon SM; Kim YS; Kim JJ; Ryu HJ; Kim YJ; Choi JW; Park HS; Kim DG; Shin HD; Rutherford MS; Oh B; Lee JK
    Biochem Biophys Res Commun; 2008 Apr; 368(2):395-401. PubMed ID: 18243134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology.
    Chen CJ; Chen DS
    Hepatology; 2002 Nov; 36(5):1046-9. PubMed ID: 12395312
    [No Abstract]   [Full Text] [Related]  

  • 32. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.
    Xiong XD; Fang JH; Qiu FE; Zhao J; Cheng J; Yuan Y; Li SP; Zhuang SM
    Mutat Res; 2008 Aug; 643(1-2):70-4. PubMed ID: 18640135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
    Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
    Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.
    Bae HJ; Eun JW; Noh JH; Kim JK; Jung KH; Xie HJ; Park WS; Lee JY; Nam SW
    Oncol Rep; 2009 Sep; 22(3):475-80. PubMed ID: 19639191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.
    Wu LM; Zhang F; Xie HY; Xu X; Chen QX; Yin SY; Liu XC; Zhou L; Xu XB; Sun YL; Zheng SS
    Clin Genet; 2008 Mar; 73(3):273-8. PubMed ID: 18177474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
    Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
    Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma: susceptibility markers.
    Blum HE
    IARC Sci Publ; 2001; 154():241-4. PubMed ID: 11220663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
    Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
    Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.